Mucin dispersions as a model for the oromucosal mucus layer in in vitro and ex vivo buccal permeability studies of small molecules

被引:24
作者
Marxen, Eva [1 ]
Mosgaard, Mette Dalskov [1 ,3 ]
Pedersen, Anne Marie Lynge [2 ]
Jacobsen, Jette [1 ]
机构
[1] Univ Copenhagen, Fac Hlth & Med Sci, Dept Pharm, Univ Pk 2, Copenhagen, Denmark
[2] Univ Copenhagen, Fac Hlth & Med Sci, Dept Odonrol, Norre Alle 20, Copenhagen, Denmark
[3] Tech Univ Denmark, Dept Micro & Nanotechnol, Orsteds Pl, Lyngby, Denmark
关键词
Mucus; Permeability; Barrier; Buccal drug delivery; Drug diffusion; Absorption; Small molecules; TR146; CELL-CULTURE; DRUG PERMEATION; ORAL-CAVITY; GASTROINTESTINAL MUCUS; MUCOSA; EPITHELIUM; PH; ABSORPTION; DELIVERY; BARRIER;
D O I
10.1016/j.ejpb.2017.09.016
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The mucus layer is believed to play a part in drug permeation across the oral mucosa. Human freeze-dried saliva (HFDS) and porcine gastric mucin (PGM) was evaluated as model for mucus layer per se or in conjunction with in vitro and ex vivo buccal permeability models. Four small molecules (nicotine, mannitol, propranolol, caffeine) showed decreased permeability across mucin dispersions, compared to controls, and a greater effect was seen with HFDS than with PGM. Permeability of propranolol and caffeine across filter-grown TR146 cells was decreased by the presence of mucin, whereas no effect was found on nicotine and mannitol. Incubation of porcine buccal mucosa with mucin dispersions for 24 h compromised the integrity of the tissue, whereas 30 min incubation did not affect tissue integrity. Tissue incubation with mucin dispersions did not decrease nicotine permeability. For the studied model drugs, it is concluded that mucin dispersions constitute a minor barrier for drug diffusion compared to the epithelium.
引用
收藏
页码:121 / 128
页数:8
相关论文
共 44 条
[1]  
ALLEN A, 1984, SCAND J GASTROENTERO, V19, P101
[2]   A comparative ex vivo drug permeation study of beta-blockers through porcine buccal mucosa [J].
Amores, Sonia ;
Lauroba, Jacinto ;
Calpena, Ana ;
Colom, Helena ;
Gimeno, Alvaro ;
Domenech, Jose .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 468 (1-2) :50-54
[3]  
Balmer RT., 1978, Biorheology, V181, P125
[4]   A tunable Caco-2/HT29-MTX co-culture model mimicking variable permeabilities of the human intestine obtained by an original seeding procedure [J].
Beduneau, Arnaud ;
Tempesta, Camille ;
Fimbel, Stephane ;
Pellequer, Yann ;
Jannin, Vincent ;
Demarne, Frederic ;
Lamprecht, Alf .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2014, 87 (02) :290-298
[5]   Transport of lipophilic drug molecules in a new mucus-secreting cell culture model based on HT29-MTX cells [J].
Behrens, I ;
Stenberg, P ;
Artursson, P ;
Kissel, T .
PHARMACEUTICAL RESEARCH, 2001, 18 (08) :1138-1145
[6]   The limiting role of mucus in drug absorption: Drug permeation through mucus solution [J].
Bhat, PG ;
Flanagan, DR ;
Donovan, MD .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 126 (1-2) :179-187
[7]  
Brodin B, 2010, MOL BIOPHARMACEUTICS, P135
[8]   pH-dependent conformational change of gastric mucin leads to sol-gel transition [J].
Cao, XX ;
Bansil, R ;
Bhaskar, KR ;
Turner, BS ;
LaMont, JT ;
Niu, N ;
Afdhal, NH .
BIOPHYSICAL JOURNAL, 1999, 76 (03) :1250-1258
[9]   A mechanistic analysis to characterize oramucosal permeation properties [J].
Chen, LLH ;
Chetty, DJ ;
Chien, YW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 184 (01) :63-72
[10]   Buccal transport of flecainide and sotalol:: effect of a bile salt and ionization state [J].
Deneer, VHM ;
Drese, GB ;
Roemelé, PEH ;
Verhoef, JC ;
Lie-A-Huen, L ;
Kingma, JH ;
Brouwers, JRBJ ;
Junginger, HE .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 241 (01) :127-134